365 related articles for article (PubMed ID: 20462447)
21. Insertion (8;11) in a renal oncocytoma with multifocal transformation to chromophobe renal cell carcinoma.
Salido M; Lloreta J; Melero C; García M; Placer J; Espinet B; Villa O; Bielsa O; Gelabert-Mas A; Serrano S; Solé F
Cancer Genet Cytogenet; 2005 Dec; 163(2):160-3. PubMed ID: 16337860
[TBL] [Abstract][Full Text] [Related]
22. Decreased Mitochondrial DNA Content Drives OXPHOS Dysregulation in Chromophobe Renal Cell Carcinoma.
Xiao Y; Clima R; Busch J; Rabien A; Kilic E; Villegas SL; Timmermann B; Attimonelli M; Jung K; Meierhofer D
Cancer Res; 2020 Sep; 80(18):3830-3840. PubMed ID: 32694149
[TBL] [Abstract][Full Text] [Related]
23. FOXI1 Immunohistochemistry Differentiates Benign Renal Oncocytoma from Malignant Chromophobe Renal Cell Carcinoma.
Molnar A; Horvath CA; Czovek P; Szanto A; Kovacs G
Anticancer Res; 2019 Jun; 39(6):2785-2790. PubMed ID: 31177114
[TBL] [Abstract][Full Text] [Related]
24. HNF1β and S100A1 are useful biomarkers for distinguishing renal oncocytoma and chromophobe renal cell carcinoma in FNA and core needle biopsies.
Conner JR; Hirsch MS; Jo VY
Cancer Cytopathol; 2015 May; 123(5):298-305. PubMed ID: 25739652
[TBL] [Abstract][Full Text] [Related]
25. Leptin and its receptor: can they help to differentiate chromophobe renal cell carcinoma from renal oncocytoma?
Ng KL; Del Vecchio SJ; Samaratunga H; Morais C; Rajandram R; Vesey DA; Wood ST; Gobe GC
Pathology; 2018 Aug; 50(5):504-510. PubMed ID: 29970253
[TBL] [Abstract][Full Text] [Related]
26. The Role of Genetic Analysis in Correct Diagnosis of Eosinophilic Variant of Chromophobe Renal Cell Carcinoma.
Molnar A; Yusenko MV; Kovacs G; Banyai D
Anticancer Res; 2020 Dec; 40(12):6863-6867. PubMed ID: 33288578
[TBL] [Abstract][Full Text] [Related]
27. Differential immunohistochemical and molecular profiling of conventional and aggressive components of chromophobe renal cell carcinoma: pitfalls for diagnosis.
Chen CV; Croom NA; Simko JP; Stohr BA; Chan E
Hum Pathol; 2022 Jan; 119():85-93. PubMed ID: 34800526
[TBL] [Abstract][Full Text] [Related]
28. Spectrum of diverse genomic alterations define non-clear cell renal carcinoma subtypes.
Durinck S; Stawiski EW; Pavía-Jiménez A; Modrusan Z; Kapur P; Jaiswal BS; Zhang N; Toffessi-Tcheuyap V; Nguyen TT; Pahuja KB; Chen YJ; Saleem S; Chaudhuri S; Heldens S; Jackson M; Peña-Llopis S; Guillory J; Toy K; Ha C; Harris CJ; Holloman E; Hill HM; Stinson J; Rivers CS; Janakiraman V; Wang W; Kinch LN; Grishin NV; Haverty PM; Chow B; Gehring JS; Reeder J; Pau G; Wu TD; Margulis V; Lotan Y; Sagalowsky A; Pedrosa I; de Sauvage FJ; Brugarolas J; Seshagiri S
Nat Genet; 2015 Jan; 47(1):13-21. PubMed ID: 25401301
[TBL] [Abstract][Full Text] [Related]
29. Distinct Genomic Copy Number Alterations Distinguish Mucinous Tubular and Spindle Cell Carcinoma of the Kidney From Papillary Renal Cell Carcinoma With Overlapping Histologic Features.
Ren Q; Wang L; Al-Ahmadie HA; Fine SW; Gopalan A; Sirintrapun SJ; Tickoo SK; Reuter VE; Chen YB
Am J Surg Pathol; 2018 Jun; 42(6):767-777. PubMed ID: 29462091
[TBL] [Abstract][Full Text] [Related]
30. The Utility of ERBB4 and RB1 Immunohistochemistry in Distinguishing Chromophobe Renal Cell Carcinoma From Renal Oncocytoma.
Sun T; Hutchinson L; Zhou AG; Liu Q; Cosar EF; St Cyr M; Ninteau N; Dresser K; Cheng L; Jiang Z; Cornejo KM
Int J Surg Pathol; 2020 May; 28(3):259-264. PubMed ID: 31640438
[No Abstract] [Full Text] [Related]
31. Identification of Key Genes and Prognostic Analysis between Chromophobe Renal Cell Carcinoma and Renal Oncocytoma by Bioinformatic Analysis.
Wu H; Fan L; Liu H; Guan B; Hu B; Liu F; Hocher B; Yin L
Biomed Res Int; 2020; 2020():4030915. PubMed ID: 31998788
[TBL] [Abstract][Full Text] [Related]
32. High-resolution DNA copy number and gene expression analyses distinguish chromophobe renal cell carcinomas and renal oncocytomas.
Yusenko MV; Kuiper RP; Boethe T; Ljungberg B; van Kessel AG; Kovacs G
BMC Cancer; 2009 May; 9():152. PubMed ID: 19445733
[TBL] [Abstract][Full Text] [Related]
33. A systematic review and meta-analysis of immunohistochemical biomarkers that differentiate chromophobe renal cell carcinoma from renal oncocytoma.
Ng KL; Morais C; Bernard A; Saunders N; Samaratunga H; Gobe G; Wood S
J Clin Pathol; 2016 Aug; 69(8):661-71. PubMed ID: 26951082
[TBL] [Abstract][Full Text] [Related]
34. C-kit expression in renal oncocytomas and chromophobe renal cell carcinomas.
Huo L; Sugimura J; Tretiakova MS; Patton KT; Gupta R; Popov B; Laskin WB; Yeldandi A; Teh BT; Yang XJ
Hum Pathol; 2005 Mar; 36(3):262-8. PubMed ID: 15791570
[TBL] [Abstract][Full Text] [Related]
35. Cluster analysis of immunohistochemical profiles delineates CK7, vimentin, S100A1 and C-kit (CD117) as an optimal panel in the differential diagnosis of renal oncocytoma from its mimics.
Carvalho JC; Wasco MJ; Kunju LP; Thomas DG; Shah RB
Histopathology; 2011 Jan; 58(2):169-79. PubMed ID: 21323945
[TBL] [Abstract][Full Text] [Related]
36. Immunohistochemical analysis of cytochrome C oxidase facilitates differentiation between oncocytoma and chromophobe renal cell carcinoma.
Adam AC; Scriba A; Ortmann M; Huss S; Kahl P; Steiner S; Störkel S; Büttner R
Appl Immunohistochem Mol Morphol; 2015 Jan; 23(1):54-9. PubMed ID: 25265428
[TBL] [Abstract][Full Text] [Related]
37. Diagnostic value of cytokeratin 7 and parvalbumin in differentiating chromophobe renal cell carcinoma from renal oncocytoma.
Adley BP; Papavero V; Sugimura J; Teh BT; Yang XJ
Anal Quant Cytol Histol; 2006 Aug; 28(4):228-36. PubMed ID: 16927643
[TBL] [Abstract][Full Text] [Related]
38. Hybrid oncocytic/chromophobe renal cell tumor: An integrated genetic and epigenetic characterization of a case.
Pires-Luis A; Montezuma D; Vieira J; Ramalho-Carvalho J; Santos C; Teixeira M; Jerónimo C; Henrique R
Exp Mol Pathol; 2018 Dec; 105(3):352-356. PubMed ID: 30343009
[TBL] [Abstract][Full Text] [Related]
39. [Oncocytoma versus chromophobe renal cell carcinoma: Is there something in between?].
Lüders C; Kristiansen G
Pathologe; 2016 Mar; 37(2):153-8. PubMed ID: 26925847
[TBL] [Abstract][Full Text] [Related]
40. Differential expression of a new isoform of DLG2 in renal oncocytoma.
Zubakov D; Stupar Z; Kovacs G
BMC Cancer; 2006 Apr; 6():106. PubMed ID: 16640776
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]